the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
Published 1 year ago • 264 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:13
is chemotherapy still a valid treatment for cll?
-
1:36
chemotherapy and allohsct in the treatment of all
-
2:00
the use of chemotherapy in r/r hodgkin and non-hodgkin lymphomas
-
1:17
still a role for chemoimmunotherapy in cll: green results
-
1:12
cancer treatment: chemotherapy
-
2:36
intensive induction chemotherapy vs hma/ven in npm1-mutant aml: a retrospective study
-
1:39
optimizing chemotherapy in aml
-
12:33
lessons in blood cancer: how far we have come cml
-
25:00
what it's like going through chemotherapy: three rounds down!
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
3:03
allosct outcomes after immunotherapy vs chemotherapy in patients with r/r nhl: a retrospective study
-
5:21
chemo-free regimens in lymphoma
-
5:26
how does chemotherapy work? - hyunsoo joshua no
-
1:43
why are new molecules typically combined with standard chemotherapy?
-
4:48
how to reduce the side effects of chemotherapy
-
1:37
the role of ctdna in hodgkin lymphoma
-
0:59
is chemoimmunotherapy in the relapsed/refractory setting still useful in cll?
-
1:40
intensive chemotherapy for aml: do we still need it?
-
6:21
prognostic significance of pet-ct status after first line immuno-chemotherapy for fl
-
3:56
what does chemotherapy actually do to your body?
-
12:59
having chemotherapy and other treatments in the day treatment unit